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Stimulation of Brain AMP-Activated Protein Kinase Attenuates
Inflammation and Acute Lung Injury in Sepsis
Nikhil Mulchandani,1 Weng-Lang Yang,1,2 Mohammad Moshahid Khan,2 Fangming Zhang,2
Philippe Marambaud,3 Jeffrey Nicastro,1 Gene F Coppa,1 and Ping Wang1,2
1

Department of Surgery, Hofstra North Shore-LIJ School of Medicine, Manhasset, New York, United States of America; 2Center for
Translational Research and 3Litwin-Zucker Research Center for the Study of Alzheimer’s Disease, The Feinstein Institute for Medical
Research, Manhasset, New York, United States of America

Sepsis and septic shock are enormous public health problems with astronomical financial repercussions on health systems
worldwide. The central nervous system (CNS) is closely intertwined in the septic process but the underlying mechanism is still obscure. AMP-activated protein kinase (AMPK) is a ubiquitous energy sensor enzyme and plays a key role in regulation of energy homeostasis and cell survival. In this study, we hypothesized that activation of AMPK in the brain would attenuate inflammatory responses in sepsis, particularly in the lungs. Adult C57BL/6 male mice were treated with 5-aminoimidazole-4-carboxamide
ribonucleotide (AICAR, 20 ng), an AMPK activator, or vehicle (normal saline) by intracerebroventricular (ICV) injection, followed by
cecal ligation and puncture (CLP) at 30 min post-ICV. The septic mice treated with AICAR exhibited elevated phosphorylation of
AMPKα in the brain along with reduced serum levels of aspartate aminotransferase, tumor necrosis factor-α (TNF-α), interleukin-1β
(IL-1β) and interleukin-6 (IL-6), compared with the vehicle. Similarly, the expressions of TNF-α, IL-1β, keratinocyte-derived chemokine
and macrophage inflammatory protein-2 as well as myeloperoxidase activity in the lungs of AICAR-treated mice were significantly
reduced. Moreover, histological findings in the lungs showed improvement of morphologic features and reduction of apoptosis
with AICAR treatment. We further found that the beneficial effects of AICAR on septic mice were diminished in AMPKα2 deficient
mice, showing that AMPK mediates these effects. In conclusion, our findings reveal a new functional role of activating AMPK in the
CNS to attenuate inflammatory responses and acute lung injury in sepsis.
Online address: http://www.molmed.org
doi: 10.2119/molmed.2015.00179

INTRODUCTION
Sepsis and septic shock are life-threatening medical conditions, characterized
by uncontrolled or overwhelming systemic inflammatory response to an infection and accounts for more than 750,000
cases annually in the United States (1).
Despite significant advances and extensive therapeutic approaches, sepsis remains a major health concern and leading
cause of high mortality worldwide (2–4).
Human and animal studies have demonstrated that progressive multiple organ
failure is the most common cause of death

following sepsis, with the lungs usually
representing the first organ to fail (5). Predisposition of the immune response has
been shown to be critical in the development of an exaggerated inflammatory reaction and ensuing acute lung injury
(ALI) (6). The clinical pathology of ALI includes increased vascular permeability, inflammation, oxidative stress, apoptosis,
pulmonary edema and the accumulation
of activated neutrophil in lung tissue and
eventually cell death (7–11).
AMP-activated protein kinase (AMPK)
is a serine/threonine kinase that functions
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as an energy sensing enzyme and is activated in response to an increase of the
AMP/ATP ratio during hypoxia, glucose
deprivation, heat shock or reduction in
mitochondrial oxidative phosphorylation
(12,13). AMPK is a heterotrimeric complex
consisting of three subunits, α catalytic
subunit and regulatory β and γ subunits
(14). Two isoforms have been identified
for both α subunit (α1 and α2) and β subunit (β1 and β2), and three isoforms have
been reported for the γ subunit (γ1, γ2 and
γ3) (14). Most recently, several reports indicate that the function of AMPK is not
only restricted to the maintenance of energy metabolism, but also to coordination
of several housekeeping mechanisms and
involvement in modulating oxidative
stress and inflammatory mediators
(15–18). An adenosine monophosphate
analog, 5-aminoimidazole-4-carboxamide
ribonucleotide (AICAR), has been used as
a pharmacological activator to upregulate
AMPK activity (19). Administering
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AICAR has been shown to inhibit inflammation and to alleviate organ injury in rodents (13,20–22).
There is growing evidence that the central nervous system (CNS) plays an important and functionally relevant role in
regulating the inflammatory response.
For example, the vagus nerve and cholinergic pathway have been demonstrated
to be involved in modulating proinflammatory cytokine-induced injury locally
and systemically in infectious diseases
(23–26). However, the molecular mechanisms of the CNS in regulating systemic
inflammation are still not well characterized. The hypothalamus, a key region in
the CNS, controls several peripheral
physiological activities through a broad
network of hormonal and neuronal communication (27). AMPKα is expressed in
hypothalamic neurons as a fuel sensor
and counteracts energy deficits in the
brain (28). More specifically, the AMPKα1
is primarily cytoplasmic, whereas
AMPKα2 is predominantly nuclear and
plays a role in transcriptional regulation
(29). In addition, the α2 catalytic subunit
is highly expressed in neurons in comparison with α1 (30). Thus, we hypothesized that activation of AMPK in the CNS
could attenuate inflammatory responses
and reduce ALI in sepsis.
In this study, we examined the mechanistic and beneficial effect of activating
centrally located AMPK in septic mice
induced by cecal ligation and puncture
(CLP). AICAR administration to the
brain through intracerebroventricular
(ICV) injection attenuated the peripheral
inflammation, as evidenced by decreased
production of cytokines and chemokines,
and reduced lung injury in septic mice.
We also provided the evidence that the
protective effect of AICAR is mediated
though the presence of AMPKα2 in the
brain by using AMPKα2 deficient mice.
MATERIALS AND METHODS
Animals
Male age-matched wild-type C57 BL/6
mice (25-30 g) (Taconic) and AMPKα2
knockout (Prkaa2–/–) mice were obtained

from Benoit Viollet (INSERM) and were
maintained at the Feinstein Institute for
Medical Research (14). They were
housed in a temperature-controlled room
on a 12-h light–dark cycle and fed a standard mouse diet. All experiments were
performed in accordance with the National Institutes of Health guidelines for
use of experimental animals (Guide for
the Care and Use of Laboratory Animals, 8th
edition, 2011), and this study was approved by the Institutional Animal Care
and Use Committee of the Feinstein Institute for Medical Research.
Intracerebroventricular (ICV) Injection
Stereotactic and surgical materials
were obtained from Stoelting and Hamilton. Animals were lightly anesthetized
with inhalational isoflurane and the head
of the animal was secured on the stereotactic apparatus. A thermal pad was used
to maintain core body temperature during the procedure. The head of the animal was shaved and cleansed with 10%
povidone-iodine wash. A midline incision was made, extending from the eyes
to the back of the cranium to expose the
bregma. Either 20 ng AICAR (SigmaAldrich) or 2 μL vehicle (normal saline)
was injected into the lateral ventricle
area by using predetermined coordinates
(AP, 0.34 mm from bregma; lateral, 1.0 m;
and vertical, 2.2 mm).
Animal Model of Sepsis
Thirty minutes after ICV injection, the
animal was removed from the stereotactic
apparatus and placed in supine position.
The ventral abdomen was shaved and
cleansed with 10% povidone–iodine wash
and cecal ligation and puncture (CLP) was
performed as previously described (31).
One- to 2-cm midline incision was performed to allow exposure of the cecum
and tightly ligated ~1.0 cm from the tip
with a 3-0 silk suture. A through double
puncture of the cecum was performed
using a 22-gauge needle. A small amount
of feces was expressed from the perforated
sites and returned to the peritoneal cavity.
The laparotomy site was then closed with
6-0 silk suture. Sham-operated animals
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underwent the same procedure with the
exception that the cecum was neither ligated nor punctured. The CLP animals subcutaneously received 1 mL isotonic normal saline immediately after the surgery.
Western Blotting
Hypothalamus and surrounding tissue
were lysed and homogenized in 300 μL
lysis buffer (10 mmol/L Tris-HCL pH 7.5,
120 mmol/L NaCl, 1% NP-40, 1% sodium
deoxycholate and 1% Triton X-100) containing protease and phosphatase inhibitor
cocktails (Roche) using a sonic dismembrator on ice. Samples were centrifuged at
14,000g for 20 min at 4°C, and the supernatant were collected. Following measurement of sample protein concentration by
Pierce BCA protein assay kit (Pierce
Biotechnology), 60 μg samples were separated on 4% to 12% Bis-Tris gradient gels
and transferred to nitrocellulose membranes. Membranes were blocked by incubation with 0.1% casein followed by incubation with primary antibody against
p-AMPKα, t-AMPKα (Cell Signaling), or
β-actin (Sigma-Aldrich). After washing,
membrane was incubated with appropriate
fluorescent secondary antibodies. Bands
were detected using the Odyssey FC DualMode Imaging system 2800 (LI-COR).
Measurements of Serum Liver
Enzymes and Cytokines
Whole-blood samples were centrifuged
at 4,000g for 12 min to collect serum, which
was then stored at –80°C before use. The
activity of aspartate aminotransferase
(AST) was determined by a commercial
assay kit from Pointe Scientific. Serum
tumor necrosis factor-α (TNF-α), interleukin 1β (IL-1β) and interleukin-6 (IL-6)
levels were determined by an enzymelinked immunosorbent assay kit specific
for mouse (BD Biosciences). The assays
were carried out according to the instructions provided by the manufacturer.
Real-Time Reverse Transcriptase–
Polymerase Chain Reaction (RT-PCR)
Analysis
Total RNA was extracted from lung tissue by TRIzol reagent (Invitrogen) and
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Table 1. A list of primer sequences used in this study.
Name

GenBank

Forward

TNF-α
IL-1β
KC
MIP-2
β-Actin

X_02611
NM_008361
NM_008176
NM_009140
NM_007393

AGACCCTCACACTCAGATCATCTTC
CAGGATGAGGACATGAGCACC
GCTGGGATTCACCTCAAGAA
CCCTGGTTCAGAAAATCATCCA
CGTGAAAAGATGACCCAGATCA

reverse-transcribed in to cDNA by using
murine leukemia virus reverse transcriptase (RT) (Applied Biosystems). A PCR
reaction was carried out in 25 μL final
volume containing 0.08 μmol of each
forward and reverse primer, 5 μL cDNA,
6.5 μL H2O and 12.5 μL SYBR Green PCR
Master Mix (Applied Biosystems). Amplification was conducted in an Applied
Biosystems 7300 real-time PCR machine
under the thermal profile of 50°C for
2 min and 95°C for 10 min, followed by
45 cycles of 95°C for 15 s and 60°C for
1 min. The level of mouse β-actin mRNA
was used for normalization and each
specific mRNA was conducted in duplicate. Relative expression of mRNA was
calculated by the 2–ΔΔCt method, and results were expressed as fold change in
comparison with controls. The sequences
of primers for this study are listed in
Table 1.
Myeloperoxidase (MPO) Activity
Assay
Lung tissues were sonicated in
50 mmol/L potassium phosphate buffer
containing 0.5% hexadecyl trimethyl
ammonium bromide. After the centrifugation, the supernatant was diluted in reaction solution containing o-dianisidine hydrochloride and H2O2. The rate of change
in optical density (OD) for 1 min was
measured at 460 nm to calculate MPO activity as described previously (32).
Histological Evaluation and Terminal
Deoxynucleotidyl Transferase dUTP
Nick-End Labeling (TUNEL) Staining of
the Lungs
Lung tissues were taken from the
upper and lower lobes 20 h following
CLP and stored in 10% formalin before
being fixed in paraffin. Tissues were then

Reverse
TTGCTACGACGTGGGCTACA
CTCTGCAGACTCAAACTCCAC
ACAGGTGCCATCAGAGCAGT
GCTCCTCCTTTCCAGGTCAGT
TGGTACGACCAGAGGCATACAG

sectioned to 4-μm cuts and stained with
hematoxylin-eosin. For TUNEL staining,
fluorescence staining was performed
using a commercially available in situ
Cell Death Detection Kit (Roche). The
assay was conducted according to the
manufacturer’s instructions. The nucleus
was stained with propidium iodide. Results were expressed as the average
number of TUNEL-positive staining cells
per 10 microscopic fields.
Statistical Analysis
All data are expressed as a mean ± SE
(n = 6–8/group) and compared by oneway analysis of variance (ANOVA) and
the Student-Newman-Keuls (SNK) test.
Differences in values were considered
significant if P < 0.05.

after CLP, the serum level of AST, an
organ injury marker, increased by 7.4-fold
in the vehicle, compared with the sham
(Figure 2A). By contrast, AICAR treatment significantly decreased the AST
level by 36.7% as compared with the vehicle group (Figure 2A). Similarly, we also
found significantly increased serum levels
of proinflammatory cytokines, TNF-α
(25.3-fold), IL-1β (24.3-fold) and IL-6 (6.8fold) in the vehicle group as compared
with the respective sham groups. Importantly, AICAR treatment significantly decreased the level of TNF-α by 70.5%, IL-1β
by 90.3%, and IL-6 by 42.2% as compared
with the vehicle (Figures 2B–D).
AICAR Ameliorates Lung Damage
and Apoptosis in Septic Mice
The lungs are very vulnerable in sepsis
(33). We examined the lung tissue at 20 h
after CLP with hematoxylin and eosin
staining. As shown in Figure 3, CLP induced severe lung injury shown with sep-

RESULTS
AICAR Activates AMPKα in the Brain of
Septic Mice
We first verified the effect of centrally
administered AICAR on the activation of
AMPKα. At 20 h after CLP, the hypothalamus sections of the mice were harvested and subjected to Western blot
analysis. The phosphorylated level of
AMPKα in the brain remained unchanged after CLP, while its level increased by 2.18-fold in the AICAR treatment group in comparison with the
vehicle treated septic mice (Figure 1).
This result indicated that ICV-injection of
IACAR effectively stimulated AMPK activity in the brain of septic mice.
AICAR Attenuates Organ Injury and
Systemic Inflammation in Septic Mice
We then examined the effect of AICAR
treatment on the tissue damage and inflammatory response in sepsis. At 20 h

Figure 1. Phosphorylation of AMPK in the
brain. The hypothalamus and surrounding
tissue of sham, vehicle- and AICAR-treated
mice were harvested at 20 h after CLP. The
tissue was lysed and subjected to Western
blotting against phosphorylated (pAMPKα) and total AMPK (t-AMPKα). Histogram shows mean densitometric analysis of bands after normalizing with t-AMPK
and β-actin. Expression in the sham group
is designated as 1 for comparison. Data
are expressed as mean ± SE (n = 6–8 per
group). *P < 0.05 versus sham and #P < 0.05
versus vehicle.
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Figure 2. Alterations in serum levels of organ injury marker and proinflammatory cytokines.
Blood of sham, vehicle- and AICAR-treated mice were harvested at 20 h after CLP for
measuring (A) AST, (B) TNF-α, (C) IL-1β, and (D) IL-6. Data are expressed as mean ± SE (n =
6–8 per group). *P < 0.05 versus sham and #P < 0.05 versus vehicle.

tal thickening, proteinaceous exudate,
pulmonary edema and enhanced inflammatory infiltrates as compared with the
sham. By contrast, the severity of lung
damage was ameliorated by AICAR treatment, shown with a better integrity of microscopic structure as compared with the
vehicle-treated animals (Figure 3).
Apoptosis plays a major role in the
pathogenesis of sepsis-induced organ injury (34). We applied TUNEL assay to examine the apoptosis in the lungs by immunofluorescence. In the vehicle group,
the TUNEL-positive cells (green fluorescence) were well detected, while they
were barely observed in the sham (Figure 4A). On the other hand, the number
of TUNEL-positive cells in the lung tissues of the AICAR-treated mice was reduced significantly (63.3%) as compared
with the vehicle group (Figure 4B).
AICAR Suppresses Lung Inflammation
and Neutrophil Infiltration in Septic
Mice
Excessive production of proinflammatory cytokines is one of the important
contributing factors for the lung injury

(35). Lung tissue was harvested at 20 h
after CLP and subjected to RT-PCR and
ELISA analysis. The mRNA level of TNF-α
was increased by 53.1-fold in vehicletreated animal as compared with the
sham. Parallel to mRNA expression, we
found increased protein levels of TNF-α

in vehicle-treated animal as compared
with the sham (Figures 5A, B). AICAR
treatments significantly suppressed
mRNA and protein levels of TNF-α by
72.5% and 44.2%, respectively, compared
with the vehicle (Figures 5A, B). Similarly, the mRNA and protein levels of IL1β were elevated significantly in the vehicle group as compared the sham, while
their levels were reduced by 76.9% and
47.4%, respectively, compared with the
vehicle (Figures 5C, D).
Chemokines keratinocyte derivedchemokine (KC) and macrophage inflammatory protein-2 (MIP-2) both have been
shown to participate in the pathogenesis
of lung injury (36,37). The mRNA levels
of KC and MIP-2 increased by 748- and
1415-fold, respectively, in the vehicle as
compared with the sham (Figures 6A, B).
By contrast, a significant reduction of KC
mRNA by 76.2% and MIP-2 mRNA by
64.2% was observed in lung tissues of
AICAR-treated mice (Figures 6A, B). We
further measured the myeloperoxidase
activity (MPO) in the lungs to evaluate
the neutrophil infiltration. The MPO activity increased by 3.1-fold in vehicletreated group as compared with the
sham, while AICAR treatment decreased
the MPO activity by 42.4% as compared
with the vehicle (Figure 6C).

Figure 3. Morphological changes in the lungs. The lung tissues of sham, vehicle- and
AICAR-treated mice were harvested at 20 h after CLP and subjected to histological analysis with hematoxylin–eosin staining. Representative images of lung histology from n = 6–8
per group. Original magnification 100× (top panels); 200× (bottom panels).
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AICAR Activity Is Mediated by
AMPKα2 in the Brain of Septic Mice
To investigate the molecular mechanism
by which AICAR treatment to the CNS attenuated organ injury and inhibited inflammation, we undertook a genetic approach. AMPKα2 is highly expressed in
the neurons of the brain. Thus, we performed the CLP in AMPKα2 knockout
(KO) mice after ICV injection of either vehicle or AICAR as described in the wildtype (WT) mice. We first measured the
serum AST level and observed its elevation in the vehicle group of AMPKα2 KO
mice, which was similar to that in the WT
mice (Figure 7A). AICAR treatment only
reduced AST levels by 13.8% without statistical significance as compared with the
vehicle (Figure 7A). Similarly, there was an
increase in serum levels of TNF-α and IL1β in septic AMPKα2 KO mice, however,
AICAR treatment did not significantly
change their levels as compared with the
vehicle (Figures 7B, C).
We also examined the mRNA levels of
proinflammatory cytokines and
chemokines in the lungs by RT-PCR.
There was an increase in mRNA levels of
TNF-α, IL-1β, KC and MIP-2 in the lungs
of vehicle-treated AMPKα2 KO mice as
compared with their respective sham
(Figures 8A–D). However, AICAR-treated
AMPKα2 KO septic mice did not show
any significant changes in the expression
levels of these cytokines and chemokines
as compared with the vehicle-treated
AMPKα2 KO septic mice (Figures 8A–D).
Taken together, these results suggest that
the protective effects of administered ICV
with AICAR in the WT mice may mainly
mediate through AMPKα2-dependent
mechanisms in the brain.
DISCUSSION
Sepsis is the leading cause of death
among critically ill patients and is the
most common risk factor for ALI. Ungoverned inflammation, characterized by
cytokine storm and subsequent neutrophil
sequestration is an underlying component
of sepsis associated organ failure (38).
Thus, elucidation of novel molecular and
cellular pathways that influence the

Figure 4. Apoptosis in the lungs after CLP. The lung tissues of sham, vehicle- and AICARtreated mice were harvested at 20 h after CLP and subjected to TUNEL assay. (A) Representative images of TUNEL staining (green fluorescent) and nuclear counterstaining (red
fluorescent) of lung sections. Original magnification 100×. Scale bar, 50 μm. (B) The number of apoptotic cells in the lung quantified from TUNEL staining. Data are expressed as
mean ± SE (n = 6–8 per group). *P < 0.05 versus sham and #P < 0.05 versus vehicle.

pathogenesis of sepsis and its associated
complication could provide greater insight
into the mechanisms of disease pathology.
The significance of the brain AMPK
stimulation in regulation of inflammation
in sepsis is not known. We have used a
combination of pharmacological and genetic approaches for the study. First, we
demonstrate that ICV injection of AICAR
markedly increases the phosphorylation
of AMPK in the brain of CLP-induced
septic mice. Such AICAR administration
reduced organ injury and inhibited systemic inflammation. In more specific organs, both the severity of damage and the
induction of apoptosis in the lungs of
septic mice are attenuated by AICAR
treatment, which is associated with a reduction of cytokine and chemokine production as well as neutrophil infiltration.
On the other hand, AICAR-mediated protective effect on lowering organ injury

and inflammation in septic WT mice is
diminished in septic AMPKα2 KO mice,
suggesting that brain AMPKα2 may be a
key player to mediate AICAR activity.
Activation of AMPK by systemic administration of AICAR has been shown to
suppress inflammatory responses in other
studies. Zhao and coworkers demonstrate
that AICAR reduces the proinflammatory
activity of neutrophils and decreases the
severity of ALI through AMPK activation,
linking to cellular responses to metabolic
stress (13). Escobar et al. demonstrate that
activation of AMPK by AICAR ameliorates liver and renal injury in septic mice,
which is associated with a decrease in circulating cytokines and tissue inflammation (39). In this study, we provide new
evidence of activating the CNS in regulating the systemic responses. By directly injecting AICAR into the brain, we have observed a significant reduction of serum
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Figure 5. Alterations in expression of proinflammatory cytokines in the lungs. The lung tissues
of sham, vehicle- and AICAR-treated mice were harvested at 20 h after CLP for measuring
the mRNA levels of (A) TNF-α and (C) IL-1β by real-time RT-PCR as well as protein levels of
(B) TNF-α and (D) IL-1β by ELISA. The mRNA expression in the sham group is designated as 1
for comparison. Data are expressed as mean ± SE (n = 6–8 per group). *P < 0.05 versus
sham and #P < 0.05 versus vehicle.

levels of proinflammatory cytokines TNFα, IL-1β and IL-6 in septic mice.
Another important aspect of our study
is to observe an improvement of lung
morphology and inhibition of lung apoptosis in septic mice with central AICAR
injection. As known, lung tissue damage
is observed in 90% of patients dying
from sepsis and its associated complication (40). The histopathological features
of lung injury in septic mice demonstrated here are resembled in the clinical
condition of patients with sepsis (41).
Other studies have indicated that apoptosis plays an important role on progression of sepsis (42,43). Oberholzer and
colleagues suggested that targeting signaling pathways that lead to apoptosis
would represent a new therapeutic target
for the patient with sepsis or other related clinical conditions (34). By systemic
administration, AICAR has been shown
to decrease the apoptosis in different
cells associated with various disease conditions (44–46). Rossi and Lord describe
that AICAR treatment decreases the neutrophil apoptosis through the AMPK ac-

tivation, suggesting an important role of
AMPK in normal function of neutrophils
(45). Similarly, Kim et al. demonstrate
that AICAR reduces the palmitate-induced apoptosis in neuron cells by activation of AMPK (46).
In addition to inhibiting systemic inflammation, central AICAR administration also decreases local inflammation in
the lungs. We have demonstrated a significant decrease in expression of cy-

tokines TNF-α.and IL-1β in the lungs
with AICAR treatment. Moreover, central
AICAR administration also effectively inhibits the expression of KC and MIP-2 in
the lungs. It has been reported that elevated expression of KC and MIP-2 potently stimulate neutrophil influx in the
lungs, while suppression of these
chemokines markedly inhibits neutrophil
sequestration in the lungs (47). Consistent with this mechanism, we have detected decreased MPO activity, a marker
for neutrophil infiltration (48). Considered together, our findings suggest that
activation of the brain AMPK by AICAR
for a protective milieu to the lung in sepsis may confer inhibition of the production of inflammatory mediators.
We then further identify the specific
target in the CNS for AICAR’s activity in
regulating systemic inflammation. When
comparing the serum levels of AST, TNFα and IL-1β in septic AMPKα2 KO mice
between vehicle and AICAR ICV injections, the beneficial effects of AICAR observed in the septic WT mice are diminished in the AMPKα2 KO mice.
Moreover, the AICAR’s effect on inhibiting the expression of cytokines and
chemokines in the lungs of the septic WT
mice disappeared in the septic AMPKα2
KO mice. These results clearly indicate
that AMPKα2 in the brain is majorly responsible for central AICAR stimulation.
As it has been indicated that the CNS can
modulate the systemic inflammation and
cytokines production by: 1) activation of

Figure 6. Alterations in expression of chemokines and myeloperoxidase activity in the
lungs. The lung tissues of sham, vehicle- and AICAR-treated mice were harvested at 20 h
after CLP for measuring the mRNA levels of (A) KC and (B) MIP-2 by real-time RT-PCR. (C)
Lung myeloperoxidase (MPO) activity was determined spectrophotometrically. The mRNA
expression in the sham group is designated as 1 for comparison. Data are expressed as
mean ± SE (n = 6–8 per group). *P < 0.05 versus sham and #P < 0.05 versus vehicle.
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vagus nerve activity and inhibits inflammation outside the CNS (55). Moreover, it
has been shown that activation of hypothalamic AMPK can prevent LPS-induced
hypoglycemia in mice liver, suggesting
centrally located AMPK in the regulation
of peripheral physiological activities (56).

Figure 7. Alterations in serum levels of organ injury marker and proinflammatory cytokines
in AMPKα2 KO mice. Blood of sham, vehicle- and AICAR-treated AMPKα2 KO mice were
harvested at 20 h after CLP for measuring (A) AST, (B) TNF-α and (C) IL-1β. Data are expressed as mean ± SE (n = 6-8 per group). P = nonsignificant (NS).

CONCLUSION
Our results suggest that centrally administered AICAR protects against sepsis-induced pulmonary injury and apoptosis, and that this protection is
associated with a decrease in circulating
proinflammatory cytokines. Furthermore,
hypothalamic AMPKα2 mediates AICAR
activity to regulate systemic inflammatory response in sepsis. Thus, further understanding the interaction between the
CNS and systemic activity will provide
another direction for sepsis treatment.
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the sympathetic nervous system and release of norepinephrine which target the
immune cells expressing adrenergic receptors (49,50); 2) stimulation of the
vagus nerve-mediated cholinergic antiinflammatory pathway (23,51,52); and 3)
activation of the hypothalamic-pituitaryadrenal (HPA) axis for glucocorticoids secretion in response to adrenocorticotropic
hormone and immune suppression
(53,54). However, which pathway(s)
serves as downstream-of-brain AMPK activation for modulating the systemic and

peripheral tissue inflammation following
sepsis needs further investigation.
By the same token, Giri et al. present
the evidence that activation of AMPKα2
by AICAR attenuates the LPS-mediated
induction of proinflammatory mediators
in rat primary astrocytes and microglia
cells through inhibiting NF-κB and
C/EBP transcription factors (22). A study
by Bernik et al. demonstrates that intracerebral administration of a tetravalent
guanylhydrazone molecule that inhibited
TNF-α production increases efferent
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